| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |